Cancer Drug Quadruples Cancer Risk!

Taken from A Code Red Alert from the Health Sciences Institute:

Cancer Drug Quadruples Cancer Risk!

Breast cancer patients – beware! Common breast cancer drug tamoxifen may quadruple your risk of developing a more aggressive cancer in your healthy breast. FOUR times the risk!

A new study (published in Cancer Research) found that tamoxifen therapy brings on a 4.4-fold increased risk of a specific, particularly aggressive form of breast cancer (called estrogen receptor negative contralateral breast cancer)...along with all of its other risks. Risks that include blood clots, stroke, and uterine cancer, just to name a few. On top of those potential risks, about 40% of women who do suffer through tamoxifen treatment suffer a cancer recurrence.

Of course, the researchers say this new finding – the four- fold risk of aggressive cancer – is no reason to stop taking tamoxifen, claiming that the benefits outweigh the risks.

DQ's note:  As I reported at www.tbyil.com in the article "Chemo Does Not Cure - Often It Inflicts Damage and Spreads Cancer" (the entire article can still be found on the home page of the website):

As reported at the 27th Annual San Antonio Breast Cancer Symposium, Dec 2004, (abstract 6014), German investigators from Friedrich-Schiller University in Jena, have shown that taxol (the "gold standard of chemo") causes a massive release of cells into circulation.

Such a release of cancer cells would result in extensive metastasis months or even years later, long after the chemo would be suspected as the cause of the spread of the cancer. This little know horror of conventional cancer treatment needs to be spread far and wide, but it is not even listed in the side effects of taxol.